Premium Research-Only Peptides

CJC-1295 (No DAC)

$72.00

- +

CJC-1295 (No DAC) is a growth hormone releasing hormone (GHRH) analog without a Drug Affinity Complex. It is extensively studied in research models for its ability to stimulate natural growth hormone release.

It is widely used in studies exploring hormonal signaling, metabolism, and body composition.

CJC-1295 (No DAC) is valued in research for its short-acting profile and ability to stimulate pulsatile growth hormone release.

CJC-1295 (No DAC), also known as Modified GRF (1-29), is a research-use-only GHRH analog used to probe GPCR-mediated signal transduction and growth hormone axis dynamics in vitro and preclinical models. Not intended for diagnostic or therapeutic use.

  • GHRH receptor activation and downstream signaling
  • Pulse-driven GH-axis modeling
  • Synergy mapping with GHSR agonists in vitro

BPC-157 | Molecular Identity & Composition

Name CJC-1295 (No DAC)
Synonyms Modified GRF (1-29) | CJC-1295 without DAC
Molecular Formula C152H252N44O42
Molecular Weight ≈3367.95 g/mol
CAS Number 863288-34-0
Appearance White to off-white lyophilized powder
Solubility Soluble in sterile water or bacteriostatic water
Purity ≥99% (HPLC)
Storage Guidelines • Lyophilized: ≤0°F (–18°C), dry, protected from light
• Reconstituted: 36–46°F (2–8°C); avoid repeat freeze–thaw
• Long-Term: Keep dry and frozen until use


Ellixon Bio Quality Advantage
  • Purity & Identity: ≥99% | HPLC & MS validated
  • Endotoxin & Sterility: <0.05 EU/mg | Third-party verified
  • Stability & Process: Controlled nucleation lyophilization | Stability-focused procedures
  • Formulation & QA: PhD-Formulated | GMP / ISO-Aligned manufacturing
  • Packaging: Luxe Fridge-Ready Box

Category Overview | Signal Transduction Pathways

Signal transduction peptides are used in RUO studies to explore how cells send and receive messages. These models interrogate receptor engagement, second-messenger production, and pathway integration across cell types.

Exciting Areas of Study

  • How cellular signals initiate chain reactions in lab models
  • Peptide effects on messaging pathways (GHRH–GHSR axes)
  • Cell responses to stress in controlled in vitro systems
  • Models of disrupted signaling in preclinical research
  • Map GPCR signaling kinetics and downstream cascades

CJC-1295 (No DAC) | Research Modeling & Applications
  • Characterize GHRH-receptor signaling and cAMP dynamics
  • Profile GH-axis pulse modeling in vitro
  • Benchmark synergy with Ipamorelin in co-treatment studies

Research Use Disclaimer

This product is supplied for laboratory research use only (RUO) and is intended solely for qualified professionals in a controlled research setting. It is not a drug, food, dietary supplement, cosmetic, or medical device, and is not intended for human or veterinary use or for any diagnostic, therapeutic, or clinical application. It is not for household use.

No statement on this page has been evaluated by the U.S. Food and Drug Administration. Nothing herein is intended to diagnose, treat, cure, or prevent any disease, nor to suggest any dosage, route, or method of administration. Ellixon Bio makes no representation or warranty, express or implied, regarding fitness for any purpose other than research and provides no medical or professional advice. The purchaser and end user assume full responsibility for safe handling, storage, and use in accordance with all applicable laws, regulations, and institutional safety protocols, and accept all associated risk and liability.

See our Terms & Conditions and our Research Compliance Disclaimers for complete terms.

Lot numberStrengthAnalysis dateTestingCertificate
EBL-CJC1295ND-0726-0128-1001 10 MGAugust 9, 2026Purity & Net Peptide TestingView PDF
Scroll to Top